Atlas Trials

The Role of Serum Adipokines in Predicting Response to Neoadjuvant Therapy in Patients With Rectal Cancer

Clinical trial NCT04598984 · UNKNOWN

Trial details

NCT number
NCT04598984
Sponsor
Istanbul Training and Research Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Rectal Cancer Stage III
Start date
2020-09-01
Primary completion
2022-12-30
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.